Global Assisted Reproductive Technology Market to Reach USD 49.30 Billion by 2033 – Rising Infertility Rates and Technological Advancements Fuel Growth
renubresearch 
The global assisted reproductive technology (ART) market is set to experience substantial growth, expanding from USD 27.76 billion in 2024 to USD 49.30 billion by 2033, registering a CAGR of 6.59% during the forecast period 2025–2033, according to the latest research study by Renub Research. Key factors driving this growth include increasing infertility rates, advances in reproductive medicine, rising awareness about fertility treatments, and supportive government policies worldwide.
Rising Global Infertility Rates Drive ART Demand
Infertility is a growing health concern globally, affecting both men and women due to lifestyle factors, delayed parenthood, stress, obesity, and medical conditions such as polycystic ovary syndrome (PCOS) and endometriosis. The World Health Organization (WHO) reports that infertility affects nearly 1 in 6 adults globally. Assisted reproductive technologies, including in-vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and cryopreservation, have emerged as vital solutions to address this growing problem.
Key Growth Drivers of the Assisted Reproductive Technology Market
1. Increasing Prevalence of Infertility
The rising number of couples experiencing difficulties in conceiving naturally has significantly boosted the demand for fertility treatments. Medical advancements and greater social acceptance of ART are helping more couples achieve parenthood.
2. Technological Advancements in Reproductive Medicine
The ART industry is witnessing rapid innovation, including improvements in embryo freezing, genetic screening (PGT), time-lapse embryo imaging, and the use of AI to select viable embryos. These advancements increase success rates, reduce multiple pregnancies, and optimize treatment costs.
3. Government Policies and Insurance Coverage
Several countries are offering supportive policies, tax benefits, or partial insurance coverage for ART procedures. This support, coupled with the growing availability of affordable fertility solutions, is expanding the market globally.
4. Growing Number of Fertility Clinics
The global expansion of fertility clinics and ART centers, particularly in developing economies, has made advanced fertility treatments more accessible and affordable.
5. Rising Awareness and Delayed Parenthood
Urbanization, career-oriented lifestyles, and delayed marriages have increased the number of couples seeking fertility treatments. Awareness campaigns and educational initiatives are also playing a critical role in reducing the stigma surrounding ART procedures.
Market Segmentation Analysis
By Technology
-
In-Vitro Fertilization (IVF)
-
Intracytoplasmic Sperm Injection (ICSI)
-
Cryopreservation (Egg and Embryo Freezing)
-
Artificial Insemination
-
Other Technologies (e.g., GIFT, ZIFT)
Among these, IVF dominates the ART market due to its high success rate and widespread use globally. ICSI, an advanced IVF technique, is also gaining traction, especially for male infertility cases.
By End-User
-
Fertility Clinics
-
Hospitals
-
Research and Academic Institutes
Fertility clinics hold the largest market share, as they provide specialized treatment options, advanced equipment, and experienced professionals.
By Gender
-
Female Infertility Treatments
-
Male Infertility Treatments
-
Combined (Couple-based) Treatments
While female infertility treatments currently dominate, awareness about male infertility is increasing, leading to a higher demand for male-specific ART solutions.
Regional Insights: Asia-Pacific Leads Growth
North America
North America is a leading market due to the presence of advanced healthcare infrastructure, high awareness, and increasing adoption of ART procedures. The U.S. dominates this region, supported by strong insurance coverage and advanced fertility technologies.
Europe
Europe is another significant market, driven by countries like Spain, Denmark, and the UK, where ART is widely accepted and often supported by government subsidies.
Asia-Pacific
The Asia-Pacific region is projected to witness the fastest growth during 2025–2033. Rising infertility rates, increasing disposable incomes, medical tourism, and the availability of affordable ART treatments in countries like India, Thailand, and China are fueling demand.
Middle East & Africa
Growing investments in healthcare infrastructure and fertility centers, along with cultural acceptance of ART, are contributing to the growth of this market in the Middle East.
Competitive Landscape
The global ART market is highly competitive, with companies focusing on improving success rates, reducing treatment costs, and expanding their geographic footprint. Key players include:
-
Vitrolife AB
-
CooperSurgical, Inc.
-
Merck KGaA
-
FUJIFILM Irvine Scientific
-
Ferring Pharmaceuticals
-
Genea Limited
-
Cook Medical
-
IVI-RMA Global
These companies are investing heavily in research and development, acquiring smaller fertility centers, and collaborating with hospitals to enhance service offerings.
Emerging Trends in the Assisted Reproductive Technology Market
-
AI and Machine Learning in Embryo Selection
Advanced AI algorithms are helping embryologists select the best quality embryos, increasing the success rate of IVF cycles. -
Genetic Testing and Personalized Fertility Treatments
Preimplantation genetic testing (PGT) allows for the selection of genetically healthy embryos, reducing the risk of genetic disorders. -
Fertility Preservation Solutions
With the growing trend of delayed parenthood, egg and sperm freezing services are becoming more popular among both men and women. -
Medical Tourism for ART Treatments
Countries like India and Thailand are emerging as popular destinations for affordable and high-quality fertility treatments. -
Improved Success Rates with Cryopreservation
Vitrification technology for egg and embryo freezing has improved survival rates, leading to better ART outcomes.
Challenges Facing the ART Market
While the ART industry is growing rapidly, it faces challenges such as the high cost of treatments, ethical and legal concerns, and emotional stress associated with infertility procedures. Additionally, success rates still vary, making ongoing research and innovation essential.
10 Frequently Asked Questions (FAQs)
1. What is the size of the global assisted reproductive technology market?
The global ART market was valued at USD 27.76 billion in 2024.
2. What is the forecasted market size by 2033?
The market is expected to reach USD 49.30 billion by 2033.
3. What is the expected CAGR of the ART market?
The market is projected to grow at a CAGR of 6.59% during 2025–2033.
4. What are the main drivers of the ART market?
Key drivers include rising infertility rates, technological advancements, and growing awareness of fertility treatments.
5. Which ART technology is most widely used?
In-vitro fertilization (IVF) is the most widely used and dominant ART technology.
6. Which region is witnessing the fastest growth?
The Asia-Pacific region is expected to see the fastest growth due to medical tourism and affordable treatments.
7. What role does AI play in ART?
AI enhances embryo selection, improves treatment success rates, and reduces trial-and-error in fertility procedures.
8. Who are the leading players in the global ART market?
Top players include Vitrolife AB, CooperSurgical, Merck KGaA, FUJIFILM Irvine Scientific, and Ferring Pharmaceuticals.
9. What trends are shaping the future of ART?
Trends include genetic testing, fertility preservation, AI integration, and increased accessibility via medical tourism.
10. What challenges does the ART industry face?
Challenges include high costs, varying success rates, ethical concerns, and emotional strain on patients.
New Publish Report:
- Japan Cardiac Bio Implant Devices Market Trends & Future Outlook
- Australia Cardiac Arrhythmia Monitoring Devices Market Outlook & Trends
- Australia Radiofrequency Ablation Device Market Outlook & Key Trends
About Renub Research
Renub Research is a Market Research and Consulting Company with more than 15 years of experience, especially in international Business-to-Business Research, Surveys, and Consulting. We provide a wide range of business research solutions that help companies make better business decisions. We partner with clients across all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Our wide clientele includes key players in Healthcare, Travel & Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemicals, Logistics & Automotive, Consumer Goods & Retail, Building & Construction, and Agriculture. Our core team comprises experienced professionals with graduate, postgraduate, and Ph.D. qualifications in Finance, Marketing, Human Resources, Bio-Technology, Medicine, Information Technology, Environmental Science, and more.
Media Contact
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +91-120-421-9822 (IND) | +1-478-202-3244 (USA)
Email: [email protected]
